Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression.
Saved in:
| Title: | Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression. |
|---|---|
| Authors: | Yun H; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Narayan N; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Vohra S; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Giotopoulos G; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Mupo A; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK.; Epigenetics Programme, The Babraham Institute, Cambridge, UK., Madrigal P; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Sasca D; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Hematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany., Lara-Astiaso D; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Horton SJ; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Agrawal-Singh S; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Meduri E; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Basheer F; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Marando L; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Gozdecka M; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK., Dovey OM; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK., Castillo-Venzor A; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK., Wang X; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Gallipoli P; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Müller-Tidow C; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Osborne CS; Department of Medical and Molecular Genetics, King's College London, London, UK., Vassiliou GS; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK., Huntly BJP; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk. |
| Source: | Nature genetics [Nat Genet] 2021 Oct; Vol. 53 (10), pp. 1443-1455. Date of Electronic Publication: 2021 Sep 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34556857 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yun+H%22">Yun H</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Narayan+N%22">Narayan N</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Vohra+S%22">Vohra S</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Giotopoulos+G%22">Giotopoulos G</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mupo+A%22">Mupo A</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK.; Epigenetics Programme, The Babraham Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Madrigal+P%22">Madrigal P</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sasca+D%22">Sasca D</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Hematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Lara-Astiaso+D%22">Lara-Astiaso D</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Horton+SJ%22">Horton SJ</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Agrawal-Singh+S%22">Agrawal-Singh S</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Meduri+E%22">Meduri E</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Basheer+F%22">Basheer F</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Marando+L%22">Marando L</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Gozdecka+M%22">Gozdecka M</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dovey+OM%22">Dovey OM</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Castillo-Venzor+A%22">Castillo-Venzor A</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Gallipoli+P%22">Gallipoli P</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Osborne+CS%22">Osborne CS</searchLink>; Department of Medical and Molecular Genetics, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Vassiliou+GS%22">Vassiliou GS</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Huntly+BJP%22">Huntly BJP</searchLink>; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216904%22">Nature genetics</searchLink> [Nat Genet] 2021 Oct; Vol. 53 (10), pp. 1443-1455. <i>Date of Electronic Publication: </i>2021 Sep 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Co%22">Nature Pub. Co </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9216904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1718 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210614036%22">10614036 </searchLink><i>NLM ISO Abbreviation: </i>Nat Genet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34556857 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41588-021-00925-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1443 Titles: – TitleFull: Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yun H – PersonEntity: Name: NameFull: Narayan N – PersonEntity: Name: NameFull: Vohra S – PersonEntity: Name: NameFull: Giotopoulos G – PersonEntity: Name: NameFull: Mupo A – PersonEntity: Name: NameFull: Madrigal P – PersonEntity: Name: NameFull: Sasca D – PersonEntity: Name: NameFull: Lara-Astiaso D – PersonEntity: Name: NameFull: Horton SJ – PersonEntity: Name: NameFull: Agrawal-Singh S – PersonEntity: Name: NameFull: Meduri E – PersonEntity: Name: NameFull: Basheer F – PersonEntity: Name: NameFull: Marando L – PersonEntity: Name: NameFull: Gozdecka M – PersonEntity: Name: NameFull: Dovey OM – PersonEntity: Name: NameFull: Castillo-Venzor A – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Gallipoli P – PersonEntity: Name: NameFull: Müller-Tidow C – PersonEntity: Name: NameFull: Osborne CS – PersonEntity: Name: NameFull: Vassiliou GS – PersonEntity: Name: NameFull: Huntly BJP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2021 Oct Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1546-1718 Numbering: – Type: volume Value: 53 – Type: issue Value: 10 Titles: – TitleFull: Nature genetics Type: main |
| ResultId | 1 |